Targeting ferroptosis in pancreatic cancer: a double-edged sword

X Chen, R Kang, G Kroemer, D Tang - Trends in Cancer, 2021 - cell.com
Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy with a 5-year
survival rate below 10%. Its unique genetic makeup and tumor microenvironment produce a …
被引用次数：99 相关文章

Targeting ferroptosis in pancreatic cancer: a double-edged sword

X Chen, R Kang, G Kroemer, D Tang - Trends in cancer, 2021 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy with a 5-year
survival rate below 10%. Its unique genetic makeup and tumor microenvironment produce a …

Targeting ferroptosis in pancreatic cancer: a double-edged sword

X Chen, R Kang, G Kroemer, D Tang - Trends in Cancer, 2021 - Elsevier
HighlightsDespite continued research, pancreatic ductal adenocarcinoma (PDAC) is still
one of the deadliest solid tumors, with an increasing incidence and lack of effective targeted …

Targeting ferroptosis in pancreatic cancer: a double-edged sword

X Chen, R Kang, G Kroemer… - Trends in …, 2021 - utsouthwestern.elsevierpure.com
Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy with a 5-year
survival rate below 10%. Its unique genetic makeup and tumor microenvironment produce a …

Targeting ferroptosis in pancreatic cancer: a double-edged sword

X Chen, R Kang, G Kroemer, D Tang - Trends in Cancer, 2021 - cell.com
Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy with a 5-year
survival rate below 10%. Its unique genetic makeup and tumor microenvironment produce a …

Targeting ferroptosis in pancreatic cancer: a double-edged sword.

X Chen, R Kang, G Kroemer, D Tang - Trends in Cancer, 2021 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy with a 5-year
survival rate below 10%. Its unique genetic makeup and tumor microenvironment produce a …